Skip to content
Review

Artificial Intelligence applied to surgical pathology in the management of cutaneous melanoma.

Oct 2026 · Presse medicale · pp. 104382 · 0 citations · 48 references
Medicine

TL;DR

A comprehensive overview of the current state and future perspectives of AI in management of cutaneous melanoma is provided, enabling the extraction of morphological and spatial features that are imperceptible to the human eye.

Abstract

Surgical pathology remains the cornerstone for the diagnosis, staging and prognostic stratification of cutaneous melanoma. The emergence of digital pathology and artificial intelligence (AI), notably deep learning, is transforming this field. Convolutional neural networks trained on large repositories of digitised histological slides demonstrate diagnostic capabilities comparable, and in specific tasks superior, to board-certified dermatopathologists. Current applications encompass the automated classification of melanocytic lesions, including the challenging differentiation between benign naevi and early melanoma. Beyond morphological diagnosis, AI algorithms extract virtual biomarkers directly from haematoxylin-eosin-stained slides, predicting underlying molecular alterations, including BRAF mutational status, and offering a transformative approach to prognostic stratification, enabling the extraction of morphological and spatial features that are imperceptible to the human eye. Challenges remain, including dataset bias, inter-laboratory standardisation of whole slide imaging workflows, model interpretability, and medico-legal accountability. The regulatory landscape is rapidly evolving: the European Union Artificial Intelligence Act classifies medical AI as high-risk. The 2024 FDA de novo authorization of DermoSensor, an adjunctive AI-enabled device for assessing suspicious skin lesions, illustrates broader progress in dermatologic AI, although it does not concern surgical pathology. This review provides a comprehensive overview of the current state and future perspectives of AI in management of cutaneous melanoma. These new tools will augment the central role of the pathologist in precision oncology, in refining adjuvant treatment decisions and surveillance strategies in routine clinical practice.

View source

Similar papers

#explainable ai Review Open access Sep 2026

Melanoma Prognostication Using AI‐Guided Histopathology

This review examines how computational pathology and convolutional neural networks (CNNs) can improve histopathologic diagnosis and risk stratification of melanoma, evaluate current image-based deep learning (DL) approaches, and outline a path toward explainable, multimodal prognostic tools.

Eudora Lee, R. Karagenova, Y. Semenov · 1 citation
Open access Oct 2026

Artificial intelligence at the surgeon–pathologist interface: revolutionizing diagnosis, prognostication, and precision surgery

Artificial intelligence applications in surgical pathology encompass tumour detection, histological classification, grading, biomarker assessment, lymph node evaluation, margin analysis, and outcome prediction. Deep learning algorithms have demonstrated high diagnostic performance across multiple malignancies including...

Umang K. Agrawal, Sakshi Jaiswal, Deepanshu Singh · 0 citations
Open access Sep 2026

Deep Learning Classification of Uveal Melanoma and Metastatic Carcinoma on Cytology Specimens: A Single-Center Experience

Purpose Differentiating between a choroidal melanoma and metastatic carcinoma to the choroid on cytological specimens presents significant diagnostic challenges due to subtle morphological differences in the sparse cells available in the sample and the increasing scarcity of specialist ocular pathologists. This study d...

Maxine Jackson, H. Kalirai, Rumana N. Hussain et al. · 0 citations
Review Open access Oct 2026

Artificial Intelligence in Diagnostic Pathology: A Narrative review on Current Applications, Emerging Challenges, and Future Perspectives

Advancements in digital pathology and whole-slide imaging have enabled Artificial Intelligence (AI) to emerge as a transformative tool in diagnostic pathology. AI has enabled the automated analysis of histopathological images, improving diagnostic accuracy and reproducibility, as well as workflow efficiency. The aim of...

Alka Yadav, Mithilesh Yadaw · 0 citations
Open access Oct 2026

Artificial Intelligence in Histopathology for Accurate Disease Diagnosis

AI is revolutionizing histopathology through its ability to enhance diagnostic precision, efficiency, and uniformity in disease identification and classification. The use of machine learning and deep learning algorithms allows for automated analysis of digital tissue images, which is helpful for cancer detection, tumor...

Muhammad Anas · 0 citations
Review Open access Sep 2026

Artificial Intelligence–Assisted Histopathological Assessment of Dysplastic and Premalignant Lesions Across Multiple Organ Systems

Objective: Artificial Intelligence (AI) based digital pathology shows promise in enhancing the histopathological evaluation of dysplastic and premalignant lesions. However, conventional grading of oral epithelial dysplasia, cervical intraepithelial neoplasia, gastric intestinal metaplasia, adenoma, and ductal carcinoma...

Hafsa Aslam, Abdullah Ehsan, Yaqoob Khizar · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.